MediPress Health – Limited Partnership has completed an IPO
MediPress Health – Limited Partnership has completed a fundraising to refinance and develop the business.
The venture MediPress Health – Limited Partnership is a public R&D life science partnership that invests in medical R&D companies specialized in digital and advanced breakthrough technologies. The venture is managed by an accomplished team with proven experience and an innovative team from the medical, technology and investments industry.
Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.
Talk to the deal team
Related deals
A group of Chilean investors has acquired Farmacias Ahumada
A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.
Learn moreAlcidion has raised capital
Alcidion Group Ltd. (ASX:ALC) has raised capital via an institutional placement. The placement was well supported by existing shareholders whilst also welcoming several new institutional shareholders to the register. Proceeds from the raise will provide Alcidion with maximum flexibility and ensure a strong balance sheet to execute on its market opportunities and enable the firm to continue to drive revenue growth.
Learn moreShield Therapeutics has completed a fundraising
Shield Therapeutics plc has raised funds to bolster the expansion of ACCRUFeR®, the sole FDA-approved therapy for iron deficiency and to drive the business. Additionally, it positions the company for further investments.
Learn more